| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $249K | -62.7% | +74.1% |
| SG&A Expense | $2.0M | -19.5% | +15.6% |
| Operating Income | -$7.4M | -137.4% | -153.0% |
| Interest Expense | $100K | — | — |
| Pre-tax Income | -$7.5M | -295.1% | -158.7% |
| Income Tax | -$1.1M | — | — |
| Net Income | -$6.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.9M | -10.8% | +7.8% |
| Total Assets | $45.4M | -10.9% | +1559.7% |
| Current Liabilities | $15.6M | -9.2% | +65.1% |
| Total Liabilities | $22.7M | -10.3% | — |
| Stockholders' Equity | $22.7M | -11.4% | +438.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | — | — |
| Financing Cash Flow | $7.4M | — | — |
| -121.1% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |